CUE Cue Biopharma

Cue Biopharma earnings company data as of 7:18 PM ET 8/21

History

1 period · newest first · EPS & Rev stacked

Period	Date	Metric	Estimate	Actual	Result
FY2026 Q2	14 Aug	EPS	-1.69	—	—
FY2026 Q2	14 Aug	Rev	—	$7.9M	—

Recent issuer filings from EDGAR · 18 shown · open Filing / Doc on SEC.gov

Filed	Form	Detail	Links
Aug 14, 2026	8-K	2.02	Filing Doc
Aug 14, 2026	10-Q		Filing Doc
Aug 3, 2026	8-K	5.02	Filing Doc
Jul 10, 2026	8-K	1.01,3.02,5.02,8.01,9.01	Filing Doc
Jun 3, 2026	8-K	5.02,5.07,9.01	Filing Doc
Jun 2, 2026	8-K	5.02,8.01	Filing Doc
May 14, 2026	10-Q		Filing Doc
May 14, 2026	8-K	9.01	Filing Doc
May 1, 2026	8-K	1.01,3.02,5.02,8.01,9.01	Filing Doc
Apr 22, 2026	8-K	3.03,5.03	Filing Doc
Apr 13, 2026	8-K	5.07	Filing Doc
Apr 7, 2026	8-K	8.01	Filing Doc
Mar 27, 2026	8-K	5.02	Filing Doc
Mar 27, 2026	DEFA14A		Filing Doc
Mar 16, 2026	10-K		Filing Doc
Mar 16, 2026	8-K	2.02,9.01	Filing Doc
Feb 18, 2026	8-K	8.01	Filing Doc
Feb 12, 2026	8-K	5.02	Filing Doc

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed	Form	Detail	Links
Aug 28, 2026	4/A	Period Jul 9, 2026 · 2 forms	Filing Doc
Aug 17, 2026	4	Period Aug 13, 2026 · 2 forms	Filing Doc
Aug 14, 2026	4	Period Aug 12, 2026	Filing Doc

Updated 9 days ago Source: SEC EDGAR submissions All on EDGAR

Consensus estimates · SEC filings remain the official record · not investment advice